Comparable stake leader
Winklevoss Capital Fund, LLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001509745.
Comparable stake leader
Winklevoss Capital Fund, LLC
Disclosed value leader
Winklevoss Capital Fund, LLC
Comparable rows
50/50
Latest evidence
17 Aug 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Winklevoss Capital Fund, LLC |
3/4/5
13D/G
10%+ Owner
|
20%
from 13D/G
|
$22,366,276
184,204,799 shares
mixed-class rows
|
— | 17 Aug 2026 |
| Severns Sean Michael |
13D/G
|
11%
|
$2,760,000
6,000,000 shares
|
$0 | 12 Nov 2025 |
| BeOne Medicines Ltd. |
3/4/5
13D/G
10%+ Owner · BeiGene, Ltd.
|
0.97%
from 13D/G
|
$20,943,045
7,348,437 shares
|
— | 24 Sep 2021 |
| James H. Cavanaugh |
3/4/5
Director
|
0.14%
|
$118,274
168,963 shares
|
— | 13 Mar 2026 |
| Joseph Loscalzo |
3/4/5
Director
|
0.14%
|
$118,125
168,750 shares
|
— | 13 Mar 2026 |
| Richard Schilsky |
3/4/5
Director
|
0.14%
|
$118,125
168,750 shares
|
— | 13 Mar 2026 |
| Christopher Mirabelli |
3/4/5
Director
|
0.1%
|
$92,632
130,376 shares
|
-$42,630 | 26 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
3.1%
|
$2,379,195
3,887,574 shares
|
— | 30 Jun 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$77,030.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 20,000 | $0 | $34,400 | -$34,400 |
| 3-6 | 0 | 60,000 | $0 | $42,630 | -$42,630 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-20 of 27 reporting-owner rows connected to CYPHERPUNK TECHNOLOGIES INC.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Winklevoss Capital Fund, LLC | 10%+ Owner | $22,366,276 | Mixed | 17 Aug 2026 | ||
| BeOne Medicines Ltd. | 10%+ Owner | $20,943,045 | Filing P/S | 24 Sep 2021 | ||
| William P. McEvoy III | Chief Investment Officer, Director, 10%+ Owner | $19,029,009 | Mixed | 17 Aug 2026 | ||
| Winklevoss Capital Management, LLC | 10%+ Owner | $15,218,479 | Median | 17 Aug 2026 | ||
| Cameron Howard Winklevoss | 10%+ Owner | $15,218,479 | Median | 17 Aug 2026 | ||
| Tyler Howard Winklevoss | 10%+ Owner | $15,218,479 | Median | 17 Aug 2026 | ||
| Winklevoss Treasury Investments, LLC | 10%+ Owner | $15,218,479 | Median | 17 Aug 2026 | ||
| GILEAD SCIENCES, INC. | 10%+ Owner | $15,159,572 | Mixed | 10 Apr 2024 | ||
| Thomas John Dietz | Director | $227,900 | -$34,400 | -13% | Filing P/S | 26 Aug 2026 |
| Augustine Lawlor | Chief Operating Officer | $221,064 | Mixed | 30 Jun 2025 | ||
| Kevin Zhang | Head of Mining | $202,612 | Median | 21 Aug 2026 | ||
| Douglas E. Onsi | CEO,CFO,Pres.,GC,Treas.&Sec., Director | $180,590 | Mixed | 01 Jul 2026 | ||
| James H. Cavanaugh | Director | $118,274 | Mixed | 13 Mar 2026 | ||
| Nissim Mashiach | Director | $118,125 | Mixed | 01 Jul 2026 | ||
| Richard Schilsky | Director | $118,125 | Mixed | 13 Mar 2026 | ||
| Khing Djien Oei | Director | $118,125 | Mixed | 01 Jul 2026 | ||
| William Li | Director | $118,125 | Mixed | 01 Jul 2026 | ||
| Christian M. Richard | Director | $118,125 | Mixed | 01 Jul 2026 | ||
| Patricia A. Martin | Director | $118,125 | Mixed | 01 Jul 2026 | ||
| Joseph Loscalzo | Director | $118,125 | Mixed | 13 Mar 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Thomas John Dietz | CYPH | Common Stock | Sale | -13.1% | $34,400 | $1.72 | -20,000 | 132,500 | 26 Aug 2026 | Direct |
| Kevin Zhang | CYPH | Restricted Stock Units | Award | -50% | -2,000,000 | 2,000,000 | 21 Aug 2026 | Direct | ||
| William P. McEvoy III | CYPH | Common Stock | Exercise of in-the-money or at-the-money derivative security | 200% | 16,570,852 | 24,854,613 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| William P. McEvoy III | CYPH | Pre-Funded Warrant (Right to Buy) | Other | 73.5% | 43,290,042 | 102,167,808 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| William P. McEvoy III | CYPH | Pre-Funded Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | -22% | -16,570,852 | 58,877,766 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Common Stock | Exercise of in-the-money or at-the-money derivative security | 200% | 16,570,852 | 24,854,613 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Common Stock | Exercise of in-the-money or at-the-money derivative security | 200% | 16,570,852 | 24,854,613 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Common Stock | Exercise of in-the-money or at-the-money derivative security | 200% | 16,570,852 | 24,854,613 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Common Stock | Exercise of in-the-money or at-the-money derivative security | 200% | 16,570,852 | 24,854,613 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Common Stock | Exercise of in-the-money or at-the-money derivative security | 200% | 16,570,852 | 24,854,613 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Other | 73.5% | 43,290,042 | 102,167,808 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Other | 73.5% | 43,290,042 | 102,167,808 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Other | 73.5% | 43,290,042 | 102,167,808 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Other | 73.5% | 43,290,042 | 102,167,808 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Other | 73.5% | 43,290,042 | 102,167,808 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | -22% | -16,570,852 | 58,877,766 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | -22% | -16,570,852 | 58,877,766 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | -22% | -16,570,852 | 58,877,766 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | -22% | -16,570,852 | 58,877,766 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Winklevoss Capital Fund, LLC | CYPH | Pre-Funded Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | -22% | -16,570,852 | 58,877,766 | 17 Aug 2026 | By Winklevoss Treasury Investments, LLC | ||
| Christian M. Richard | CYPH | Restricted Stock Units | Award | -50% | -75,000 | 75,000 | 01 Jul 2026 | Direct | ||
| Khing Djien Oei | CYPH | Restricted Stock Units | Award | -50% | -100,000 | 100,000 | 01 Jul 2026 | Direct | ||
| Thomas John Dietz | CYPH | Restricted Stock Units | Award | -50% | -100,000 | 100,000 | 01 Jul 2026 | Direct | ||
| Patricia A. Martin | CYPH | Restricted Stock Units | Award | -50% | -75,000 | 75,000 | 01 Jul 2026 | Direct | ||
| William Li | CYPH | Restricted Stock Units | Award | -50% | -75,000 | 75,000 | 01 Jul 2026 | Direct | ||
| Douglas E. Onsi | CYPH | Restricted Stock Units | Award | -50% | -1,000,000 | 1,000,000 | 01 Jul 2026 | Direct | ||
| William Patrick McEvoy III | CYPH | Restricted Stock Units | Award | -50% | -1,000,000 | 1,000,000 | 01 Jul 2026 | Direct | ||
| Nissim Mashiach | CYPH | Restricted Stock Units | Award | -50% | -75,000 | 75,000 | 01 Jul 2026 | Direct | ||
| Christopher Mirabelli | CYPH | Common Stock | Sale | -31.5% | $42,630 | $0.7105 | -60,000 | 130,376 | 26 Mar 2026 | Direct |
| Thomas John Dietz | CYPH | Common Stock | Options Exercise | 217.7% | 104,500 | 152,500 | 13 Mar 2026 | Direct | ||
| Thomas John Dietz | CYPH | Restricted Stock Units | Options Exercise | -100% | -104,500 | 0 | 13 Mar 2026 | Direct | ||
| Christopher Mirabelli | CYPH | Common Stock | Options Exercise | 780.3% | 168,750 | 190,376 | 13 Mar 2026 | Direct | ||
| Christopher Mirabelli | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| Khing Djien Oei | CYPH | Common Stock | Options Exercise | 168,750 | 168,750 | 13 Mar 2026 | Direct | |||
| Khing Djien Oei | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| William Li | CYPH | Common Stock | Options Exercise | 168,750 | 168,750 | 13 Mar 2026 | Direct | |||
| William Li | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| Christian M. Richard | CYPH | Common Stock | Options Exercise | 168,750 | 168,750 | 13 Mar 2026 | Direct | |||
| Christian M. Richard | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| Nissim Mashiach | CYPH | Common Stock | Options Exercise | 168,750 | 168,750 | 13 Mar 2026 | Direct | |||
| Nissim Mashiach | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| Patricia A. Martin | CYPH | Common Stock | Options Exercise | 168,750 | 168,750 | 13 Mar 2026 | Direct | |||
| Patricia A. Martin | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| Richard Schilsky | CYPH | Common Stock | Options Exercise | 168,750 | 168,750 | 13 Mar 2026 | Direct | |||
| Richard Schilsky | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| Joseph Loscalzo | CYPH | Common Stock | Options Exercise | 168,750 | 168,750 | 13 Mar 2026 | Direct | |||
| Joseph Loscalzo | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| James H. Cavanaugh | CYPH | Common Stock | Options Exercise | 79225.4% | 168,750 | 168,963 | 13 Mar 2026 | Direct | ||
| James H. Cavanaugh | CYPH | Restricted Stock Units | Options Exercise | -100% | -168,750 | 0 | 13 Mar 2026 | Direct | ||
| Thomas John Dietz | LPTX | Common Stock | Tax liability | -42.2% | -35,000 | 48,000 | 26 Dec 2025 | Direct |